LOGIN  |  REGISTER
Terns Pharmaceuticals
Astria Therapeutics

Enhabit Announces Participation in Bank of America Home Care Conference 2025

December 02, 2025 | Last Trade: US$9.68 0.08 0.83

DALLAS / Dec 02, 2025 / Business Wire / Enhabit, Inc. (NYSE: EHAB), a leading national home health and hospice provider, today announced its participation in the Bank of America Home Care Conference 2025.

Enhabit’s President and CEO Barb Jacobsmeyer and Chief Financial Officer Ryan Solomon will participate in a fireside chat on Tuesday, Dec. 9, at 2:50 p.m. CT. The fireside chat will be webcast live at https://bofa.veracast.com/webcasts/bofa/homecare2025/M4EufU.cfm, and a replay will be available at the same URL within 24 hours after the event’s conclusion. Both the live webcast and replay will also be accessible on Enhabit's investor website under “Events & Presentations.”

About Enhabit Home Health & Hospice

Enhabit Home Health & Hospice (Enhabit, Inc.) is a leading national home health and hospice provider working to expand what’s possible for patient care in the home. Enhabit's team of clinicians supports patients and their families where they are most comfortable, with a nationwide footprint spanning 247 home health locations and 115 hospice locations across 34 states. Enhabit leverages advanced technology and compassionate teams to deliver extraordinary patient care. For more information, visit enhabit.com.

Terns Pharmaceuticals

Stock Quote

Featured Stock

Amneal Pharmaceuticals

Amneal Pharmaceuticals is a fully-integrated essential medicines company. We make healthy possible through the development, manufacturing, and distribution of generic and specialty pharmaceuticals. The Company has a diverse portfolio of over 250 products in its Generics segment and is expanding across...

CLICK TO LEARN MORE

Featured Stock

Cue Biopharma

Cue Biopharma is developing the first-ever class of therapeutics for the treatment of cancer that mimic the natural signals, or “Cues”, of the immune system. This novel class of injectable biologics selectively engages and modulates tumor-specific T cells directly within the patient’s body to transform...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page